医院前脉冲剂量葡萄糖皮质体在ST段升高心肌梗塞:PULSE-MI随机临床试验
Jasmine Melissa Madsen1, Thomas Engstrøm1,2, Laust Emil Roelsgaard Obling1
1Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
JAMA cardiology
|August 30, 2024
概括
在ST段升高心肌梗塞 (STEMI) 患者中,医院前的葡萄糖皮质激素治疗没有减少最终心脏病发作的大小. 然而,早期治疗显示急性心脏参数有所改善,尽管试验可能不足.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 紧急医疗 紧急医疗
背景情况:
- 在ST段升高心肌梗塞 (STEMI) 中的急性炎症与心肌损伤程度相关.
- 早期干预葡萄糖皮质类药物可以减轻心脏病发作的大小.
研究的目的:
- 评估在STEMI患者中医院前脉冲剂量葡萄糖皮质激素的心脏保护疗效.
主要方法:
- 一个随机的,盲目的,安慰剂对照试验,涉及530名STEMI患者.
- 患者接受了静脉注射甲基prednisolone (250毫克) 或安慰剂医院前.
- 主要结局:3个月后通过心磁共振 (CMR) 评估最终的心脏病发作大小.
主要成果:
- 在葡萄糖皮质醇和安慰剂组之间,3个月的最终心脏病发作大小没有显著差异 (5%与6%,P=.24).
- 葡萄糖皮质醇组的急性心脏病发作大小较小,微血管阻塞较少,急性左心室喷射率较大.
- 二次临床结果和不良事件在各组之间是相似的.
结论:
- 医院前脉冲剂量葡萄糖皮质体并没有减少STEMI患者在3个月后的最终心脏病大小.
- 由于心脏病发作大小小小于预期,这项研究可能不足.
- 早期服用葡萄糖皮质类药物显示在急性心脏参数方面具有潜在的益处.
更多相关视频
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
24.2K
07:50Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
4.6K
相关概念视频
01:30Pulse rhythm
775
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
775
01:26Heart Failure Drugs: Inotropic Agents
545
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
545